Clinical Trials in Ohio

Showing 6841-6860 of 20,938 trials

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

NCT00826280

Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI

Coronary Artery Disease (CAD)

Astellas Pharma Inc347 participantsStarted Mar 2009

Birmingham, Alabama, United States • Huntsville, Alabama, United States • La Mesa, California, United States +22 more locations

COMPLETEDPhase 1/232 miles

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

NCT03163511

VC02-101 will evaluate an experimental cell replacement therapy intended to provide a functional cure to subjects with Type 1 Diabetes and Hypoglycemia Unawareness.

Type 1 Diabetes Mellitus With Hypoglycemia

ViaCyte49 participantsStarted Jul 2017

Duarte, California, United States • Irvine, California, United States • Sacramento, California, United States +7 more locations

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Find Trials by Condition in Ohio

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

Evaluation of Clear Aligner Trays to Straighten Teeth

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke

ProACT Post-Approval Study

Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors

Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique

The PediQUEST Response Intervention Study

Acorai Machine Learning Generalization (MLG) Study

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Randomized Study of Silq Urinary Catheter

Human Laboratory Study of ASP8062 for Alcohol Use Disorder

Audio Distraction for Traction Pin Placement

A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis